SPIA
OYST

Steward Partners Investment Advisory’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Steward Partners Investment Advisory’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-400
Closed -$8K – 3521
2020
Q4 		$8K Hold
400
– – ﹤0.01% 2395
2020
Q3 		$8K Hold
400
– – ﹤0.01% 2236
2020
Q2 		$12K Buy
+400
New +$12.1K ﹤0.01% 1987

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Steward Partners Investment Advisory's OYST Position: Q1 2021 in Review

Steward Partners Investment Advisory sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2021, closing a stake of 400 shares — an estimated $8K sold.

Steward Partners Investment Advisory first reported a position in OYST in Q2 2020 and held it in 3 quarters. The position peaked at $12K in Q2 2020. 61 funds tracked by Wall St. Rank hold OYST as of Q1 2021.

  • Steward Partners Investment Advisory reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 400 Oyster Point Pharma, Inc. Common Stock shares in Q1 2021, an estimated $8K.
  • Steward Partners Investment Advisory first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
  • Steward Partners Investment Advisory's Oyster Point Pharma, Inc. Common Stock position peaked at $12K in Q2 2020.
  • 61 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2021.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2021, filed 14 May 2021.